Invention Grant
- Patent Title: Topical pharmaceutical formulation
-
Application No.: US16308032Application Date: 2017-06-07
-
Publication No.: US11376213B2Publication Date: 2022-07-05
- Inventor: Adrian Davis , Marc Barry Brown
- Applicant: Futura Medical Developments Limited
- Applicant Address: GB Guildford
- Assignee: Futura Medical Developments Limited
- Current Assignee: Futura Medical Developments Limited
- Current Assignee Address: GB Guildford
- Agency: Stites & Harbison, PLLC
- Agent Terry L. Wright
- Priority: GB1609968 20160607
- International Application: PCT/GB2017/051649 WO 20170607
- International Announcement: WO2017/212260 WO 20171214
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K47/10 ; A61K47/14 ; A61K31/192 ; A61P29/00 ; A61K9/08

Abstract:
There is described a topical composition for application of an NSAID comprising ibuprofen, the composition comprising a solution or suspension of the NSAID as active ingredient in a residual carrier system comprising a polyhydric alcohol, a glycol ether, an ester of a higher fatty acid and optionally water, the ingredients of the residual carrier system having the following concentrations in percentages by weight: polyhydric alcohol 50-90 glycol ether 7.5-40 ester 0.5-5 water optional in which either the composition or the residual phase is in a single phase under ambient conditions and the maximum water concentration is that above which the composition or the residual phase exhibits signs of inhomogeneity.
Public/Granted literature
- US20190216721A1 TOPICAL PHARMACEUTICAL FORMULATION Public/Granted day:2019-07-18
Information query